Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000

被引:86
作者
Cheeta, S [1 ]
Schifano, F [1 ]
Oyefeso, A [1 ]
Webb, L [1 ]
Ghodse, AH [1 ]
机构
[1] Univ London St Georges Hosp, Sch Med, Dept Addict Behav & Psychol Med, London SW17 0RE, England
关键词
D O I
10.1192/bjp.184.1.41
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Deaths from antidepressants continue to account for a substantial proportion of drug-related deaths. Aims To investigate the relative toxicity of the major classes of antidepressant drugs, with the specific objective of assessing this in relation to the cause of death; and to analyse the deaths where there were multiple mentions of antidepressant drugs or other psychoactive drugs with antidepressants. Method Mortality data were collected from the National Programme of Substance Abuse Deaths, and antidepressant prescription data were collected. Results Most deaths from antidepressant drugs were suicides (80%). Tricyclic antidepressants (TCAs) accounted for more drug mentions than did other antidepressant drugs (12 per million prescriptions). Selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly lower risk of toxicity, but 93% of deaths from SSRIs occurred in combination with other drugs, especially TCAs (24.5%). In 'combination' deaths patients were significantly more likely to have had a history of drug misuse. Conclusions The efficacy and safety of augmentation therapy with TCAs in SSRI-resistant patients should be monitored carefully, and patients prescribed antidepressants should be screened for drug use/misuse. Declaration of interest None.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 28 条
  • [1] Ables AZ, 2003, AM FAM PHYSICIAN, V67, P547
  • [2] BLAND JM, 1990, CLINSTAT USERS GUIDE
  • [3] Cardiovascular and neurological toxicity of venlafaxine
    Blythe, D
    Hackett, LP
    [J]. HUMAN & EXPERIMENTAL TOXICOLOGY, 1999, 18 (05) : 309 - 313
  • [4] Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data
    Buckley, NA
    McManus, PR
    [J]. BRITISH MEDICAL JOURNAL, 2002, 325 (7376): : 1332 - 1333
  • [5] THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES
    CREWE, HK
    LENNARD, MS
    TUCKER, GT
    WOODS, FR
    HADDOCK, RE
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) : 262 - 265
  • [6] The effect of lofepramine and other related agents on the motility of Tetrahymena pyriformis
    Darcy, P
    Kelly, JP
    Leonard, BE
    Henry, JA
    [J]. TOXICOLOGY LETTERS, 2002, 128 (1-3) : 207 - 214
  • [7] Suboptimal use of antidepressants in the treatment of depression
    Donoghue, J
    Taylor, DM
    [J]. CNS DRUGS, 2000, 13 (05) : 365 - 383
  • [8] Donoghue J. M., 1996, British Journal of Psychiatry, V168, P164, DOI 10.1192/bjp.168.2.164
  • [9] Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine
    Drent, M
    Singh, S
    Gorgels, APM
    Hansell, DM
    Bekers, O
    Nicholson, AG
    van Suylen, RJ
    du Bois, RM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (07) : 958 - 961
  • [10] Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines
    Dunn, RL
    Donoghue, JM
    Ozminkowski, RJ
    Stephenson, D
    Hylan, TR
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1999, 13 (02) : 136 - 143